Early Vigabatrin Treatment Before Seizure Onset Decreased Interictal Epileptiform Discharges Over the Duration of the PREVeNT Study.

Saved in:
Bibliographic Details
Title: Early Vigabatrin Treatment Before Seizure Onset Decreased Interictal Epileptiform Discharges Over the Duration of the PREVeNT Study.
Authors: McPherson TO; Department of Biostatistics and Bioinformatics, Emory University, Atlanta, Georgia., Bebin EM; Department of Neurology, University of Alabama at Birmingham, Birmingham, Alabama., Farach LS; Department of Pediatrics, McGovern Medical School at the University of Texas Health Science Center at Houston (UTHealth Houston) and Children's Memorial Hermann Hospital, Houston, Texas., Wulsin AC; Department of Neurology, Boston Children's Hospital, Harvard Medical School, Boston, Massachusetts., Davis P; Department of Neurology, Boston Children's Hospital, Harvard Medical School, Boston, Massachusetts., Au KS; Division of Medical Genetics, Department of Pediatrics, McGovern Medical School at UTHealth Houston, Houston, Texas., Sahin M; Department of Neurology, Boston Children's Hospital, Harvard Medical School, Boston, Massachusetts., Wu JY; Division of Pediatric Neurology, Department of Pediatrics, David Geffen School of Medicine, UCLA Mattel Children's Hospital, Los Angeles, California., Taub KS; Department of Pediatrics, Children's Hospital of Philadelphia, Philadelphia, Pennsylvania., Rajaraman R; Department of Pediatrics and Psychiatry and Biobehavioral Sciences, University of California, Los Angeles, Los Angeles, California., Randle S; Seattle Children's Hospital, Seattle, Washington., McClintock WM; Department of Neurology, Children's National Hospital, Washington, District of Columbia., Koenig MK; Division of Child Neurology, Department of Pediatrics, McGovern Medical School at UTHealth Houston, Houston, Texas., Frost MD; Minnesota Epilepsy Group, Roseville, Minnesota., Northrup H; Division of Medical Genetics, Department of Pediatrics, McGovern Medical School at UTHealth Houston, Houston, Texas., Werner K; Department of Pediatrics, Duke University, Durham, North Carolina., Nolan D; Beaumont Florence and Richard McBrien Pediatric Neuroscience Center, Beaumont Hospital, Royal Oak, Michigan., Wong M; Department of Neurology, Washington University in Saint Louis, Saint Louis, Missouri., Krefting J; Department of Neurology, University of Alabama at Birmingham, Birmingham, Alabama., Peri K; Department of Biostatistics, University of Alabama at Birmingham, Birmingham, Alabama., Cutter G; Department of Biostatistics, University of Alabama at Birmingham, Birmingham, Alabama., Krueger D; Department of Pediatrics, University of Cincinnati, Cincinnati, Ohio., Peters JM; Department of Neurology, Boston Children's Hospital, Harvard Medical School, Boston, Massachusetts., Porter BE; Department of Neurology, Stanford University, Stanford, California.
Corporate Authors: PREVeNT Study Group
Source: Pediatric neurology [Pediatr Neurol] 2026 Jun; Vol. 179, pp. 30-36. Date of Electronic Publication: 2026 Mar 11.
Publication Type: Journal Article; Randomized Controlled Trial
Journal Info: Publisher: Elsevier Science Publishing Country of Publication: United States NLM ID: 8508183 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1873-5150 (Electronic) Linking ISSN: 08878994 NLM ISO Abbreviation: Pediatr Neurol Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1873-5150
DOI:10.1016/j.pediatrneurol.2026.03.005